Table 5. Multinomial logistic regression analysis of rs762623 with nationality included as a covariate.

Fibrosis stage	EST (SE)	OR (L95–U95)	P value
Stage 0 vs. stage 1	0.7632 (0.2631)	2.145 (1.281–3.593)	0.0037
Stage 0 vs. stage 2	1.1522 (0.3151)	3.165 (1.707–5.869)	0.0003
Stage 0 vs. stage 3	0.8175 (0.3279)	2.265 (1.191–4.307)	0.0127
Stage 0 vs. stage 4	0.6975 (0.4146)	2.009 (0.891–4.527)	0.0925
Stage 1 vs. stage 2	0.3890 (0.3066)	1.476 (0.809–2.691)	0.2045
Stage 1 vs. stage 3	0.05432 (0.3206)	1.056 (0.563–1.979)	0.8655
Stage 1 vs. stage 4	−0.0657 (0.4079)	0.936 (0.421–2.083)	0.8720
Stage 2 vs. stage 3	−0.3347 (0.3487)	0.716 (0.361–1.417)	0.3372
Stage 2 vs. stage 4	−0.4548 (0.4287)	0.635 (0.274–1.470)	0.2888
Stage 3 vs. stage 4	−0.1201 (0.4366)	0.887 (0.377–2.087)	0.7833

Multinomial logistic regression to determine the effect of rs762623 on the development of different stages of fibrosis in the combined UK and Finnish Cohort, with nationality included as a covariate. The reference level of fibrosis ranges from fibrosis stage 0 to 4. EST, estimate of the effect; SE, standard error of the estimate; OR odds ratio; L95 lower 95% confidence interval of the odds ratio; U95 upper 95% confidence interval of the OR.